US EditionTrump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
The draft order would hit patented drugs and ingredients unless companies strike direct-to-consumer deals or shift production to the United States.
- United States President Donald Trump signed an executive order allowing up to 100% tariffs on some imported patented drugs if pharmaceutical companies do not make pricing deals or build facilities in the US.
- Companies with 'most favored nation' pricing deals and active US manufacturing face zero tariffs, while others building US projects face tariffs starting at 20% and escalating to 100% over four years.
96 Articles
96 Articles
On Thursday, April 2, Donald Trump signed several decrees to introduce new tariffs on imported drugs and pharmaceutical ingredients. The objective is to accelerate American reindustrialization in the sector.
Government promises to keep medicine prices the same after Trump imposes 100% tariff
Australian medicines won't get more expensive. That's the pledge from the federal government after President Donald Trump slapped a 100% tariff on some branded medicines imported to the United States - giving big companies a deadline of 120 days to make a deal. The tariffs imposed at a time of growing global economic uncertainty amid the president's continued war in the Middle East.
The Times of Northwest Indiana
Trump hits drugmakers with potential tariffs
WASHINGTON — President Donald Trump signed an executive order Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S. unless manufacturers agree to government drug pricing deals or commit to making their products domestically.
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
